Analytical Testing

EXECUTIVE INTERVIEW - GATC Health & Liquid Biosciences: Faster, Cheaper, More Effective Drug Discovery

Ian Jenkins, Director of Science, and Jeff Moses, CMO at GATC Health, discuss the combined benefits of their MAT platform and Liquid Biosciences’ Emerge mathematical evolution platform to help identify the right biology sooner and focus on a smaller set of potential compounds early in the pre-clinical development process to enable pharma companies to develop drugs with more efficiency and a higher success rate.

Inotiv, Inc. & Synexa Life Sciences Sign Letter of Intent to Establish Center of Excellence for Biotherapeutics & Biomarkers

Inotiv, Inc. and Synexa Life Sciences recently announced they intend to form a collaboration that will accelerate Inotiv’s development of biomarkers essential to the understanding of safety and efficacy of novel biotherapeutics, enhancing the….

Frequently Asked Questions About Analytical Testing

What are the latest trends in analytical testing for pharmaceuticals?

Recent trends include advanced automation in lab processes, predictive in silico modeling, and the adoption of diverse analytical techniques to support evolving biologics, inhaled therapies, and personalized medicines.

How are CDMOs improving resilience in analytical supply chains?

CDMOs are using multi-sourcing strategies, expanding vendor bases, and implementing flexible automation solutions to mitigate risks related to material shortages, tariffs, and geopolitical disruptions.

What role does automation play in modern analytical labs?

Automation solutions—such as semi-automated inhaled product testing and plug‑and‑play instruments—are enhancing accuracy, efficiency, and agility in testing workflows.